Follow
Robert J. Dorosky
Robert J. Dorosky
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Pseudomonas chlororaphis produces two distinct R-tailocins that contribute to bacterial competition in biofilms and on roots
RJ Dorosky, JM Yu, LS Pierson III, EA Pierson
Applied and environmental microbiology 83 (15), e00706-17, 2017
532017
The phenazine 2-hydroxy-phenazine-1-carboxylic acid promotes extracellular DNA release and has broad transcriptomic consequences in Pseudomonas chlororaphis 30–84
D Wang, JM Yu, RJ Dorosky, LS Pierson III, EA Pierson
PLoS One 11 (1), e0148003, 2016
482016
Forest harvest intensity and soil depth alter inorganic nitrogen pool sizes and ammonia oxidizer community composition
RM Mushinski, TJ Gentry, RJ Dorosky, TW Boutton
Soil Biology and Biochemistry 112, 216-227, 2017
462017
Adaptation genomics of a small-colony variant in a Pseudomonas chlororaphis 30-84 biofilm
D Wang, RJ Dorosky, CS Han, C Lo, AEK Dichosa, PS Chain, JM Yu, ...
Applied and environmental microbiology 81 (3), 890-899, 2015
422015
Pseudomonas chlororaphis produces multiple R-tailocin particles that broaden the killing spectrum and contribute to persistence in rhizosphere communities
RJ Dorosky, LS Pierson III, EA Pierson
Applied and environmental microbiology 84 (18), e01230-18, 2018
352018
Nanobodies as potential tools for microbiological testing of live biotherapeutic products
RJ Dorosky, JE Schreier, SL Lola, RL Sava, MP Coryell, A Akue, ...
AMB Express 14 (1), 9, 2024
2024
Characterization of Lactobacilli Phage Endolysins and Their Functional Domains–Potential Live Biotherapeutic Testing Reagents
RJ Dorosky, SL Lola, HA Brown, JE Schreier, SM Dreher-Lesnick, ...
Viruses 15 (10), 1986, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–7